Share this content: Patients with advanced Hodgkin lymphoma may benefit from positron-emission tomography-computed tomography (PET-CT) testing. Patients with advanced Hodgkin lymphoma may benefit from positron-emission tomography-computed ... Cancer Therapy Advisor, 3 days ago
Fine-Tuning the Treatment of Hodgkin's Lymphoma - New England Journal of Medicine, 4 days ago
Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma - New England Journal of Medicine, 4 days ago
(HealthDay News) -- A certain type of medical scan can be used to help spare some Hodgkin lymphoma patients from the severe side effects of chemotherapy, a new study suggests. Researchers found that PET imaging can identify patients whose Hodgkin ...US News & World Report, 4 days ago Scans May Spare These Patients From Chemo WebMD, 4 days ago
More from: EHE&Me, EHE&Me...and 4 other sources
Kansas City Chiefs safety Eric Berry, who overcame a diagnosis of Hodgkin lymphoma in late 2014 to return to the field and have an All-NFL season in 2015, has been selected as the 2016 George Halas Award winner by the Professional Football Writers ...WCVB.com, 6 days ago Kansas City Chiefs' Eric Berry wins Halas Award UPI, 6 days ago PFWA names Chiefs S Eric Berry recipient of George Halas Award Equilibrio Informativo, 6 days ago
14 June 2016 From the section Devon Image copyright Devon and Cornwall Police Image caption Adrian Munday's body was found at his house in Devon A man has been jailed for life for murdering and setting fire to a vulnerable person in a ...BBC, 1 week ago Man jailed for killing 'vulnerable' man BBC, 1 week ago CCTV shows how murderer stole from vulnerable man ITV.com, 1 week ago Homeless man jailed for life for murdering 'gentle giant' ITV.com, 1 week ago
New Data on Bristol-Myers Squibb's Opdivo nivolumab Indicate Benefit in Heavily Pre-Treated Classical Hodgkin Lymphoma Patients in Phase 2,...
New Data on Bristol-Myers Squibb's Opdivo nivolumab Indicate Benefit in Heavily Pre-Treated Classical Hodgkin Lymphoma Patients in Phase 2, Single-Arm Pivotal Trial By a News Reporter-Staff News Editor at Biotech Week Bristol-Myers Squibb Company ...Pharmacy Choice, 5 days ago BMS reports encouraging results from Phase II classical Hodgkin lymphoma trial PredictWallStreet, 6 days ago BMY On The CheckMate Tear: Updated Results In Hodgkin Lympoma For Opdivo Seeking Alpha, 1 week ago ONO PHARMACEUTICAL : New Data on Opdivo (nivolumab) Indicate Benefit in Heavily Pre-Treated Classical Hodgkin Lymphoma Patients in Phase 2, Single-Arm Pivotal Trial (167KB) 4 Traders, 1 week ago
Infinity Pharmaceuticals has announced it's restructuring after disappointing Phase 2 study of its treatment for non-Hodgkin lymphoma. That's on the Bay State Biotech Report, where Bloomberg biotechnology reporter Doni Bloomfield and Boston radio ...Bloomberg, 1 week ago Infinity Pharma back under a cloud after duvelisib disappoints in PhII FierceBiotech, 1 week ago
June 12--AUGUSTA -- The former Hodgkins Middle School may be undergoing a massive renovation, turning the 1958 school building into affordable apartments for senior citizens; but much of it, other than the old classrooms that are becoming new ...Bloomberg, 2 weeks ago Officials, experts tout Augusta's potential for housing development [Kennebec Journal, Augusta, Maine] Bloomberg, 5 days ago
Life Sciences JobsBioSpace, 4 days ago Epizyme Initiates Collaboration on Combination Trial of Tazemetostat and Tecentriq (atezolizumab) for Treatment of Non-Hodgkin Lymphoma Stockwatch, 5 days ago Epizyme Presents Positive Clinical Data on Tazemetostat in Relapsed or Refractory Non-Hodgkin's Lymphoma LymphomaNewsToday.com, 5 days ago Non-Hodgkin's Lymphoma, Farmers and the Use of Glyphosate: What You Should Know LymphomaNewsToday.com, 6 days ago
Early this week, Wall Street dinged Epizyme on concerns that Phase II data for its non-Hodgkin lymphoma candidate tazemetostat didn't live up to the expectations set by prior testing. But now the biotech nabbed a partner in Roche's Genentech ($ROG) ...FierceBiotech, 4 days ago Epizyme Offers Early Data on Non-Hodgkin Lymphoma Drug Zacks.com, 6 days ago
More from: , Nasdaq...and 2 other sources
/PRNewswire/ -- Rich Pharmaceuticals, Inc. (OTCPK:RCHA) ("Rich" or the "Company"), announced today it has entered into an additional agreement with Theradex Systems, Inc. ("Theradex"), a leading global Contract Research Organization ("CRO"), to ...Nasdaq, 6 days ago Rich Pharma Retains Theradex Systems To Help Advance Its Hodgkin's Lymphoma Indication BioSpace, 6 days ago
on your WebpageAdd Widget >Get your members hooked!